Cataract Surgery Device Industry Research Report 2019

1. Cataract Surgery Device Industry Cataract Surgery Device Industry Analysis 2019 Opportunities, Key Players Review by Forecast to 2023 Opportunities, Key Players Review by Forecast to 2023 Analysis 2019 – – Growth Factors, Statistics Data, Business Growth Factors, Statistics Data, Business The global Cataract Surgery Device Industry is exhibiting highly stable demand due to the rise in the global geriatric population. The aging of the baby boomer’s generation coupled with the increasing prevalence of eye disorders will continue to drive growth in the Cataract Surgery Device Industry. The global Cataract Surgery Device Industry is due to reach USD 4.5 Bn at a CAGR of 5.5% over the forecast period of 2016-2022, projects market Research Future (MRFR) in a detailed study. Get Free Sample Research Copy@ https://www.marketresearchfuture.com/sample_request/2115 Other driving factors include an increase in disposable income and the development of minimally invasive surgical procedures, less post-operation recovery time, and the economic upsurge in developing countries. Conversely, healthcare costs remain a significant factor in the acceptance of cataract surgery devices. Advanced cataract surgical devices are high priced which limits the growth of the market in price- sensitive markets. Segmentation The global Cataract Surgery Device Industry has been segmented on the basis of type and end user. On the basis of type, the global Cataract Surgery Device Industry has been segmented into intraocular lens (IOL), phacoemulsification equipment, ophthalmic viscoelastic device (OVD), and femtosecond laser equipment. On the basis of end user, the global Cataract Surgery Device Industry has been segmented into ophthalmology centers, hospitals, clinics, and others. Regional Analysis Geographically, the global Cataract Surgery Device market has been segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America accounts for the largest share of 46% of the global market. Presence of a high number of visually impaired population, increased access to healthcare, high expenditure on healthcare services drive the market in North America. Also, the region tends to swiftly adopt new advanced technologies which further boosts the growth of the cataract surgery devices market in North America. Europe is the second largest market and is expected to grow at a CAGR of 5.2% over the forecast period. Asia Pacific is expected to be the fastest growing market for cataract surgery devices while Latin America and the Middle East & Africa markets are expected to exhibit limited growth over the forecast period. Market Research Future Magarpatta Road, Hadapsar, Pune

2. Competitive Landscape M&A activities in the global Cataract Surgery Device Industry have remained steady and strong interest has been noticed on the part of financial sponsors due to positive long-term demand which has spurred the growth of the global Cataract Surgery Device Industry. Allergan, Inc. (U.S.), Opcon Corporation (Japan), Alcon, Inc. ( U.S), Essilor International S.A. (France), Bausch & Lomb, Inc. (U.S.), Carl Zeiss Meditech AG (Germany), STAAR Surgical Company (U.S.), Abbott Laboratories (U.S.), and NIDEK Co., Ltd. (Japan) are the eminent players in the global Cataract Surgery Device Industry. Brows complete Research Report@ https://www.marketresearchfuture.com/reports/cataract- surgery-device-market-2115 Substantial investment by medical devices manufactures ON R&D has resulted in the advancement of medical devices and sophisticated medical, surgical techniques such as laser technology and advanced technology lens which is expected to impact the market growth positively. Expanding the scope of medical service offerings is expected to drive new revenue opportunities for the global Cataract Surgery Device Industry. The rise in a number of FDA approvals for innovative therapies and devices for cataract surgery is also expected to create a supportive platform for the growth of the market over the forecast period. Industry Updates In December 2018, Ocular Therapeutix, a biopharmaceutical company focused on the development of innovative therapies and eye diseases, announced that the U.S. Food and Drug Administration (FDA) had approved its new eye device, Dextenza. The FDA approval comes after two rejections and this time has been approved almost a month ahead of the expected decision date. For Any Query connect@ https://www.marketresearchfuture.com/enquiry/2115 About Market Research Future: At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services. In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members. Contact: Akash Anand, Market Research Future +1 646 845 9312 Email: sales@marketresearchfuture.com Market Research Future Magarpatta Road, Hadapsar, Pune